Colorado Cancer Blogs
  • Home
  • Topics
    • Latest News
    • Research
    • Patient Care
    • Philanthropy
    • C3 Magazine
    • Honors
  • Cancer Types
    • bladder cancer
    • blood cancer
    • brain cancer
    • breast cancer
    • colorectal cancer
    • gynecologic cancer
    • head & neck cancer
    • lung cancer
    • pancreatic cancer
    • pediatric cancer
    • prostate cancer
    • sarcoma
    • skin cancer
  • Facebook
  • Twitter
Select Page
Study hints at new target to improve immune therapy in triple-negative breast cancer

Study hints at new target to improve immune therapy in triple-negative breast cancer

by Garth Sundem | May 14, 2018 | Featured, Latest News, Research

Therapies that recruit the immune system to attack tumors are revolutionizing cancer care. Among these successful immunotherapies is a class known as “checkpoint inhibitors” that unmask tumors’ ability to hide from the immune system. However, checkpoint inhibitors...
CU Cancer clinical trial takes on treatment resistant breast cancer

CU Cancer clinical trial takes on treatment resistant breast cancer

by Erika Matich | Jan 10, 2018 | Latest News, Patient Care, Research

Metastatic triple-positive breast cancer frequently resists treatments. Scientists at the University of Colorado Cancer Center are testing a unique combination of medications to change that. Growth of breast cancer cells is often propelled by one of three receptors –...
In Breast Surgery,  Sometimes Less is More

In Breast Surgery, Sometimes Less is More

by Garth Sundem | Dec 7, 2017 | C3 Magazine, Patient Care, Research

Last year when surgeon Gretchen Ahrendt, MD, was considering a move from the University of Pittsburgh to accept the position of Director of the Diane O’Connor Thompson Breast Center on the Anschutz Campus, she and her husband, Steven – also a surgical oncologist –...
In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors, including triple-negative breast cancer

In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors, including triple-negative breast cancer

by Garth Sundem | Nov 1, 2017 | Latest News, Research

Two University of Colorado Cancer Center studies were presented this weekend at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting in Philadelphia, PA showing that using the drug alisertib along with the drug TAK-228 is more effective against...
CU Cancer Center’s Traci Lyons, PhD, earns prestigious R01 and ACS RSG grants

CU Cancer Center’s Traci Lyons, PhD, earns prestigious R01 and ACS RSG grants

by Garth Sundem | Aug 22, 2017 | Honors, Latest News

A successful early-career scientist will apply for many grants and even win a few, often first from foundations and associations, perhaps from programs designed to promote the training of young researchers, and eventually from the National Institutes of Health to fund...
« Older Entries
Next Entries »

@CUCancerCenter on Twitter

  • @CUCancerCenter 2 hours

    Our director was born in Burma (now Myanmar) and lived in Thailand and India before arriving in the USA to study me… twitter.com/i/web/status/1…

  • @CUCancerCenter 3 hours

    Why don't we screen everyone for #cancer at a young age? What harm is there in screening early? How do I know if I… twitter.com/i/web/status/1…

  • @CUCancerCenter 4 hours

    CU Cancer Center doctor Ginger Borges, MD, talks with @Kim9news from 9NEWS about the increased risk of metastatic b… twitter.com/i/web/status/1…

  • @CUCancerCenter 5 hours

    Thank you 9NEWS for sharing this story! Ginger Borges, MD, talks about why young moms with young children are at hi… twitter.com/i/web/status/1…

  • @CUCancerCenter 6 hours

    Study finds mothers with breast cancer have a higher risk of metastasis compared to women without children, even 10… twitter.com/i/web/status/1…

  • @CUCancerCenter 7 hours

    New study: Breast cancer up to 5 times more likely to metastasize even 10 years after childbirth… twitter.com/i/web/status/1…

  • @CUCancerCenter 8 hours

    Do you have questions about #ORIEN? This quick video may answer them! bit.ly/CUORIEN #cancer #research… twitter.com/i/web/status/1…

  • @CUCancerCenter February 19, 2019

    Can Facebook advertising prevent cancer? An interesting idea...bit.ly/FBCancerCU #cancer #socialmedia… twitter.com/i/web/status/1…

  • @CUCancerCenter February 19, 2019

    Two new studies look at HOW ALK+ and ROS1+ #lungcancers develop resistance to therapies and whether or not a simple… twitter.com/i/web/status/1…

  • @CUCancerCenter February 19, 2019

    "No one hates cancer more than me..." Get to know our director in the latest C3 magazine! bit.ly/2QhqnQd… twitter.com/i/web/status/1…

  • @CUCancerCenter February 19, 2019

    Diagnosed with #lungcancer at 32 years old & 33 weeks pregnant, Emily is now on a mission to find a cure for the di… twitter.com/i/web/status/1…

  • @CUCancerCenter February 19, 2019

    Exercise during #cancer treatment may be beneficial! https://t.co/zdoGQj7fXk

Colorado Cancer Blogs

  • About Us
  • Comment Policy
  • Cover My News!

CU Cancer Center

  • Find a Doctor
  • Clinical Trials
  • Remote Second Opinion
  • Events

Subscribe to CU Cancer Blogs via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

  • Facebook
  • Twitter

Copyright © 2019 Colorado Cancer Blogs